Novo Nordisk posted solid quarterly results Wednesday before the market open.Sales came in at 71.3 billion Danish crowns ($10 ...

The Denmark-based drug maker Zealand Pharma said Tuesday that its experimental weight-loss drug could help patients lose ...

Kentucky, Alaska and Alabama are the three states where weight loss drugs ... U.S. Food and Drug Administration (FDA) approved the semaglutide-based drug Wegovy for obesity. Before Wegovy, 190,000 ...

Zealand Pharma A/S said moderate doses of its experimental weight-loss drug helped patients pare pounds with less nausea than ...

Only 13 states currently allow Medicaid to cover treatment of obesity using glucagon-like peptide-1 agonist (GLP-1) medications, researchers said.

Vos agrees that modelling the health effects of weight loss with GLP-1 agonists isn’t straightforward. It’s unclear, he says, ...

Poorer folks’ access to blockbuster weight-loss drugs through Medicaid remains limited, a new KFF analysis has found.O ...

I’d been wanting to lose weight for a while and the traditional methods just weren’t working for me. Deprive myself of carbs for a week and I would drop a measly 2lb. Hire a personal trainer – the ...

It was semaglutide, a drug sold under the brand names Ozempic (for diabetes) and Wegovy (for weight loss). Following ...

These drugs are collectively known as GLP-1 agonists because they mimic the body’s natural hormone GLP-1, which regulates ...

The biotech had tested the oral asset, dubbed VK2735, at doses ranging from 2.5 mg up to 100 mg. Viking already revealed back in March that 25% of the eight patients who received 20-mg doses saw their ...